Related Experiment Video

Updated: Jul 15, 2026

Myocardial Infarction and Functional Outcome Assessment in Pigs
12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

[Postinfarction management]

Jean-Pierre Monassier1, Laurent Monassier

  • 1Service de cardiologie, Hôpital Emile Muller, 20 rue du Docteur Laennec, Mulhouse (68), France. monassierj@ch-mulhouse.fr

Presse Medicale (Paris, France : 1983)
|April 28, 2007
PubMed

Insights

Individualized post-heart attack care is crucial. Key factors include ejection fraction and using antithrombotics, beta-blockers, ACE inhibitors, and statins to optimize patient outcomes.

Area of Science:

  • Cardiology
  • Pharmacology
  • Clinical Medicine

Context:

  • Post-myocardial infarction (MI) management requires personalized strategies.
  • Ejection fraction (EF) measured at one month is a critical prognostic indicator.
  • Optimal medical therapy involves a combination of antithrombotics, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors, and statins.

Purpose:

  • To outline essential components of individualized post-MI patient management.
  • To emphasize achieving target drug dosages used in clinical trials.
  • To highlight the importance of cardiovascular rehabilitation and patient education.

Summary:

  • Individualized post-MI management is essential, with ejection fraction (EF) as a key prognostic factor.
  • Core pharmacotherapy includes antithrombotics, beta-blockers, ACE inhibitors, and statins, aiming for clinical trial-proven dosages.
  • Cardiovascular rehabilitation and patient education are vital for risk factor control and appropriate medication/device use.

Impact:

  • Improved patient outcomes through tailored treatment strategies.
  • Enhanced patient adherence and understanding of medication and self-management techniques.
  • Informed decisions regarding myocardial revascularization, implantable defibrillators, and cardiac replacement based on EF and heart failure status.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis06:59

Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis

Published on: August 26, 2025

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...